Literature DB >> 19034385

Increased STAT-3 and synchronous activation of Raf-1-MEK-1-MAPK, and phosphatidylinositol 3-Kinase-Akt-mTOR pathways in atypical and anaplastic meningiomas.

Mahlon D Johnson1, Mary O'Connell, Fran Vito, Robert S Bakos.   

Abstract

The intracellular events promoting meningioma cell proliferation in high grade tumors are not established. In this study we compared 45 WHO grade I and 35 grade II or III meningiomas by Western blot or immunohistochemistry for phosphorylation/activation of the MEK-1-MAPK, PI3 K-Akt-mTOR-PRAS40 and STAT3 pathways. By Western blot, STAT3 activation was detected in 75% of grade I compared to 100% of grade II and III meningiomas. By immunohistochemistry p-STAT3 was detected in 28% of grade I compared to 65 or 66% of grade II and III meningiomas, respectively. Phosphorylated MEK-1 and p-MAPK were activated in nearly all grade I, II and III tumors. Phosphorylated Akt was also detected in the majority of meningiomas of each grade although downstream pathway component activation was less widespread. These findings suggest that there is increased STAT3 activation in WHO grade II and III meningiomas compared with grade I tumors. Moreover, each of the three major growth regulatory pathways is concomitantly activated in higher grade meningiomas.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19034385     DOI: 10.1007/s11060-008-9746-7

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  44 in total

1.  Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation.

Authors:  J Brognard; A S Clark; Y Ni; P A Dennis
Journal:  Cancer Res       Date:  2001-05-15       Impact factor: 12.701

Review 2.  The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions.

Authors:  Seunghee Yoon; Rony Seger
Journal:  Growth Factors       Date:  2006-03       Impact factor: 2.511

3.  Platelet-derived growth factor-BB and thrombin activate phosphoinositide 3-kinase and protein kinase B: role in mediating airway smooth muscle proliferation.

Authors:  T R Walker; S M Moore; M F Lawson; R A Panettieri; E R Chilvers
Journal:  Mol Pharmacol       Date:  1998-12       Impact factor: 4.436

4.  Different activation of mitogen-activated protein kinase and Akt signaling is associated with aggressive phenotype of human meningiomas.

Authors:  Christian Mawrin; Tina Sasse; Elmar Kirches; Siegfried Kropf; Thomas Schneider; Christoph Grimm; Claudia Pambor; Christian K Vorwerk; Raimund Firsching; Uwe Lendeckel; Knut Dietzmann
Journal:  Clin Cancer Res       Date:  2005-06-01       Impact factor: 12.531

5.  Evidence for phosphatidylinositol 3-kinase-Akt-p7S6K pathway activation and transduction of mitogenic signals by platelet-derived growth factor in meningioma cells.

Authors:  Mahlon D Johnson; Evelyn Okedli; Ann Woodard; Steven A Toms; George S Allen
Journal:  J Neurosurg       Date:  2002-09       Impact factor: 5.115

6.  AKT1/PKBalpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells.

Authors:  M Sun; G Wang; J E Paciga; R I Feldman; Z Q Yuan; X L Ma; S A Shelley; R Jove; P N Tsichlis; S V Nicosia; J Q Cheng
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

7.  Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells.

Authors:  R Garcia; T L Bowman; G Niu; H Yu; S Minton; C A Muro-Cacho; C E Cox; R Falcone; R Fairclough; S Parsons; A Laudano; A Gazit; A Levitzki; A Kraker; R Jove
Journal:  Oncogene       Date:  2001-05-03       Impact factor: 9.867

8.  Epidermal growth factor receptor expression in 72 meningiomas.

Authors:  N R Jones; M L Rossi; M Gregoriou; J T Hughes
Journal:  Cancer       Date:  1990-07-01       Impact factor: 6.860

Review 9.  Inhibition of the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway in hematologic malignancies.

Authors:  Thomas E Witzig; Scott H Kaufmann
Journal:  Curr Treat Options Oncol       Date:  2006-07

10.  Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells.

Authors:  Neeraj K Saxena; Dipali Sharma; Xiaokun Ding; Songbai Lin; Fabio Marra; Didier Merlin; Frank A Anania
Journal:  Cancer Res       Date:  2007-03-15       Impact factor: 12.701

View more
  20 in total

Review 1.  Translational control in cancer.

Authors:  Deborah Silvera; Silvia C Formenti; Robert J Schneider
Journal:  Nat Rev Cancer       Date:  2010-04       Impact factor: 60.716

2.  Lopinavir inhibits meningioma cell proliferation by Akt independent mechanism.

Authors:  Mahlon D Johnson; Mary O'Connell; Webster Pilcher
Journal:  J Neurooncol       Date:  2010-07-02       Impact factor: 4.130

3.  Complex interactions between the components of the PI3K/AKT/mTOR pathway, and with components of MAPK, JAK/STAT and Notch-1 pathways, indicate their involvement in meningioma development.

Authors:  Elias A El-Habr; Georgia Levidou; Eleni-Andriana Trigka; Joanna Sakalidou; Christina Piperi; Ilenia Chatziandreou; Anastasia Spyropoulou; Rigas Soldatos; Georgia Tomara; Kalliopi Petraki; Vassilis Samaras; Athanasios Zisakis; Vassilis Varsos; George Vrettakos; Efstathios Boviatsis; Efstratios Patsouris; Angelica A Saetta; Penelope Korkolopoulou
Journal:  Virchows Arch       Date:  2014-08-22       Impact factor: 4.064

4.  Analysis of transforming growth factor β receptor expression and signaling in higher grade meningiomas.

Authors:  Mahlon D Johnson; Aubie K Shaw; Mary J O'Connell; Fraser J Sim; Harold L Moses
Journal:  J Neurooncol       Date:  2010-09-19       Impact factor: 4.130

Review 5.  Frontier of epilepsy research - mTOR signaling pathway.

Authors:  Chang Hoon Cho
Journal:  Exp Mol Med       Date:  2011-05-31       Impact factor: 8.718

6.  Cerebrospinal fluid stimulates leptomeningeal and meningioma cell proliferation and activation of STAT3.

Authors:  Mahlon D Johnson; Mary O'Connell; Michael Facik; Paul Maurer; Babak Jahromi; Webster Pilcher
Journal:  J Neurooncol       Date:  2011-10-05       Impact factor: 4.130

7.  AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas.

Authors:  Matthew L Bush; Janet Oblinger; Victoria Brendel; Griffin Santarelli; Jie Huang; Elena M Akhmametyeva; Sarah S Burns; Justin Wheeler; Jeremy Davis; Charles W Yates; Abhik R Chaudhury; Samuel Kulp; Ching-Shih Chen; Long-Sheng Chang; D Bradley Welling; Abraham Jacob
Journal:  Neuro Oncol       Date:  2011-07-21       Impact factor: 12.300

8.  Analysis of several PLA2 mRNA in human meningiomas.

Authors:  Yves Denizot; Rafael De Armas; Karine Durand; Sandrine Robert; Jean-Jacques Moreau; François Caire; Nicolas Weinbreck; François Labrousse
Journal:  Mediators Inflamm       Date:  2010-03-21       Impact factor: 4.711

9.  Effect of miR-194-5p regulating STAT1/mTOR signaling pathway on the biological characteristics of ectopic endometrial cells from mice.

Authors:  Qian Zhao; Bing Han; Ying Zhang; Ke Su; Chunfang Wang; Panpan Hai; Aiping Bian; Ruixia Guo
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

10.  A six-microRNA set as prognostic indicators for bile duct cancer.

Authors:  Ming Wang; Tian-Fu Wen; Lin-Hai He; Chuan Li; Wen-Jiang Zhu; Narasimha Murthy Trishul
Journal:  Int J Clin Exp Med       Date:  2015-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.